Citadel Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.17M Sell
18,200
-3,600
-17% -$472K ﹤0.01% 5913
2025
Q4
$2.97M Sell
21,800
-6,100
-22% -$877K ﹤0.01% 5185
2025
Q3
$4.12M Sell
27,900
-194,200
-87% -$26.9M ﹤0.01% 4703
2025
Q2
$28.7M Buy
222,100
+181,600
+448% +$22M 0.01% 1727
2025
Q1
$4.84M Buy
40,500
+24,500
+153% +$3.04M ﹤0.01% 3931
2024
Q4
$1.86M Sell
16,000
-32,400
-67% -$4.1M ﹤0.01% 5781
2024
Q3
$6.54M Sell
48,400
-5,200
-10% -$696K ﹤0.01% 3521
2024
Q2
$7.27M Sell
53,600
-38,900
-42% -$5.29M ﹤0.01% 3221
2024
Q1
$12M Sell
92,500
-23,700
-20% -$2.86M ﹤0.01% 2702
2023
Q4
$13.3M Buy
116,200
+51,804
+80% +$5.17M ﹤0.01% 2479
2023
Q3
$5.86M Buy
64,396
+14,168
+28% +$1.46M ﹤0.01% 3403
2023
Q2
$5.66M Sell
50,228
-23,272
-32% -$2.46M ﹤0.01% 3458
2023
Q1
$7.7M Buy
73,500
+28,100
+62% +$2.93M ﹤0.01% 3154
2022
Q4
$5.02M Buy
45,400
+24,500
+117% +$2.57M ﹤0.01% 3855
2022
Q3
$1.83M Sell
20,900
-4,700
-18% -$427K ﹤0.01% 5759
2022
Q2
$2M Sell
25,600
-900
-3% -$74.3K ﹤0.01% 5544
2022
Q1
$2.26M Sell
26,500
-700
-3% -$67.1K ﹤0.01% 5819
2021
Q4
$3.26M Sell
27,200
-1,000
-4% -$124K ﹤0.01% 5168
2021
Q3
$3.49M Sell
28,200
-4,300
-13% -$553K ﹤0.01% 5035
2021
Q2
$3.9M Buy
32,500
+18,800
+137% +$2.15M ﹤0.01% 4993
2021
Q1
$1.44M Sell
13,700
-6,200
-31% -$629K ﹤0.01% 7206
2020
Q4
$2.03M Sell
19,900
-21,100
-51% -$1.98M ﹤0.01% 5330
2020
Q3
$3.45M Sell
41,000
-35,300
-46% -$2.75M ﹤0.01% 3735
2020
Q2
$4.96M Buy
76,300
+21,500
+39% +$1.42M ﹤0.01% 3092
2020
Q1
$3.57M Buy
54,800
+36,400
+198% +$2.87M ﹤0.01% 3191
2019
Q4
$1.45M Sell
18,400
-6,200
-25% -$483K ﹤0.01% 4929
2019
Q3
$1.96M Sell
24,600
-2,400
-9% -$189K ﹤0.01% 4516
2019
Q2
$2.26M Sell
27,000
-11,600
-30% -$924K ﹤0.01% 4303
2019
Q1
$3.05M Buy
38,600
+14,600
+61% +$1.07M ﹤0.01% 3734
2018
Q4
$1.6M Buy
24,000
+11,900
+98% +$823K ﹤0.01% 4512
2018
Q3
$966K Sell
12,100
-20,900
-63% -$1.56M ﹤0.01% 5619
2018
Q2
$2.22M Buy
33,000
+13,300
+68% +$966K ﹤0.01% 3942
2018
Q1
$1.51M Sell
19,700
-10,300
-34% -$762K ﹤0.01% 4160
2017
Q4
$2.05M Buy
30,000
+21,500
+253% +$1.43M ﹤0.01% 3600
2017
Q3
$532K Buy
8,500
+100
+1% +$5.98K ﹤0.01% 5237
2017
Q2
$466K Sell
8,400
-9,800
-54% -$510K ﹤0.01% 5224
2017
Q1
$914K Sell
18,200
-2,200
-11% -$107K ﹤0.01% 4137
2016
Q4
$1.01M Buy
20,400
+6,200
+44% +$314K ﹤0.01% 3837
2016
Q3
$745K Buy
14,200
+1,700
+14% +$83.4K ﹤0.01% 4238
2016
Q2
$558K Sell
12,500
-25,200
-67% -$1.09M ﹤0.01% 4334
2016
Q1
$1.54M Buy
37,700
+26,500
+237% +$976K ﹤0.01% 2947
2015
Q4
$409K Sell
11,200
-800
-7% -$28.9K ﹤0.01% 4753
2015
Q3
$394K Buy
12,000
+3,300
+38% +$111K ﹤0.01% 5150
2015
Q2
$323K Buy
8,700
+600
+7% +$21.8K ﹤0.01% 5650
2015
Q1
$284K Sell
8,100
-2,800
-26% -$98.8K ﹤0.01% 5728
2014
Q4
$415K Buy
10,900
+10,500
+2,625% +$384K ﹤0.01% 4976
2014
Q3
$14K Sell
400
-13,000
-97% -$483K ﹤0.01% 7654
2014
Q2
$524K Buy
13,400
+10,200
+319% +$381K ﹤0.01% 4321
2014
Q1
$117K Sell
3,200
-7,400
-70% -$270K ﹤0.01% 6051
2013
Q4
$367K Buy
10,600
+9,200
+657% +$296K ﹤0.01% 4392
2013
Q3
$39K Sell
1,400
-2,800
-67% -$74.6K ﹤0.01% 5924
2013
Q2
$113K Buy
+4,200
New +$116K ﹤0.01% 5129

Other funds holding XYL

Citadel Advisors's XYL Position: Q1 2026 in Review

Citadel Advisors increased its Xylem (XYL) stake by 242% in Q1 2026, buying an estimated $44.7M and bringing the position to 481,831 shares worth $57.6M. The position accounts for 0.01% of the portfolio, ranked #1234.

Citadel Advisors first reported a position in XYL in Q2 2013 and has held it in 47 quarters since. The position peaked at $148M in Q2 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Citadel Advisors held 481,831 shares of Xylem worth $57.6M as of Q1 2026.
  • Citadel Advisors bought 340,741 Xylem shares in Q1 2026, an estimated $44.7M.
  • Xylem made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1234 holding.
  • Citadel Advisors first reported a position in Xylem in Q2 2013 and has held it in 47 quarters since.
  • Citadel Advisors's Xylem position peaked at $148M in Q2 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.